| IL-1 receptor antagonist ameliorates inflammasome-dependent inflammation in murine and human cystic fibrosis RG Iannitti, V Napolioni, V Oikonomou, A De Luca, C Galosi, M Pariano, ... Nature communications 7 (1), 10791, 2016 | 235 | 2016 |
| The kynurenine pathway is a double-edged sword in immune-privileged sites and in cancer: implications for immunotherapy JP Routy, B Routy, GM Graziani, V Mehraj International Journal of Tryptophan Research 9, IJTR. S38355, 2016 | 189 | 2016 |
| A mast cell-ILC2-Th9 pathway promotes lung inflammation in cystic fibrosis S Moretti, G Renga, V Oikonomou, C Galosi, M Pariano, RG Iannitti, ... Nature communications 8 (1), 14017, 2017 | 129 | 2017 |
| Thymosin α1 represents a potential potent single-molecule-based therapy for cystic fibrosis L Romani, V Oikonomou, S Moretti, RG Iannitti, MC D'Adamo, VR Villella, ... Nature medicine 23 (5), 590-600, 2017 | 104 | 2017 |
| Pathogenic NLRP3 inflammasome activity during Candida infection is negatively regulated by IL-22 via activation of NLRC4 and IL-1Ra M Borghi, A De Luca, M Puccetti, M Jaeger, A Mencacci, V Oikonomou, ... Cell host & microbe 18 (2), 198-209, 2015 | 89 | 2015 |
| The aryl hydrocarbon receptor: a review of its role in the physiology and pathology of the integument and its relationship to the tryptophan metabolism R Noakes International Journal of Tryptophan Research 8, IJTR. S19985, 2015 | 76 | 2015 |
| Noncanonical fungal autophagy inhibits inflammation in response to IFN-γ via DAPK1 V Oikonomou, S Moretti, G Renga, C Galosi, M Borghi, M Pariano, ... Cell Host & Microbe 20 (6), 744-757, 2016 | 58 | 2016 |
| Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite G Renga, E Nunzi, M Pariano, M Puccetti, MM Bellet, G Pieraccini, ... Journal for immunotherapy of cancer 10 (3), 2022 | 54 | 2022 |
| A reappraisal of thymosin alpha1 in cancer therapy C Costantini, MM Bellet, M Pariano, G Renga, C Stincardini, AL Goldstein, ... Frontiers in oncology 9, 873, 2019 | 52 | 2019 |
| The IL-17F/IL-17RC axis promotes respiratory allergy in the proximal airways A De Luca, M Pariano, B Cellini, C Costantini, VR Villella, SS Jose, ... Cell reports 20 (7), 1667-1680, 2017 | 50 | 2017 |
| Kynurenine pathway in chronic kidney disease: what’s old, what’s new, and what’s next? A Mor, B Kalaska, D Pawlak International Journal of Tryptophan Research 13, 1178646920954882, 2020 | 46 | 2020 |
| Microbes in the era of circadian medicine C Costantini, G Renga, F Sellitto, M Borghi, C Stincardini, M Pariano, ... Frontiers in cellular and infection microbiology 10, 30, 2020 | 43 | 2020 |
| A systems genomics approach identifies SIGLEC15 as a susceptibility factor in recurrent vulvovaginal candidiasis M Jaeger, M Pinelli, M Borghi, C Constantini, M Dindo, L Van Emst, ... Science Translational Medicine 11 (496), eaar3558, 2019 | 41 | 2019 |
| The microbiota/host immune system interaction in the nose to protect from COVID-19 A Di Stadio, C Costantini, G Renga, M Pariano, G Ricci, L Romani Life 10 (12), 345, 2020 | 40 | 2020 |
| CAR T cells targeting Aspergillus fumigatus are effective at treating invasive pulmonary aspergillosis in preclinical models M Seif, TK Kakoschke, F Ebel, MM Bellet, N Trinks, G Renga, M Pariano, ... Science Translational Medicine 14 (664), eabh1209, 2022 | 35 | 2022 |
| Targeting the aryl hydrocarbon receptor with indole-3-aldehyde protects from vulvovaginal candidiasis via the IL-22-IL-18 cross-talk M Borghi, M Pariano, V Solito, M Puccetti, MM Bellet, C Stincardini, ... Frontiers in immunology 10, 2364, 2019 | 35 | 2019 |
| Indole-3-carboxaldehyde restores gut mucosal integrity and protects from liver fibrosis in murine sclerosing cholangitis F D’Onofrio, G Renga, M Puccetti, M Pariano, MM Bellet, I Santarelli, ... Cells 10 (7), 1622, 2021 | 29 | 2021 |
| Thymosin β4 limits inflammation through autophagy G Renga, V Oikonomou, C Stincardini, M Pariano, M Borghi, C Costantini, ... Expert opinion on biological therapy 18 (sup1), 171-175, 2018 | 27 | 2018 |
| Towards targeting the aryl hydrocarbon receptor in cystic fibrosis M Puccetti, G Paolicelli, V Oikonomou, A De Luca, G Renga, M Borghi, ... Mediators of Inflammation 2018 (1), 1601486, 2018 | 27 | 2018 |
| Enteric formulated indole-3-carboxaldehyde targets the aryl hydrocarbon receptor for protection in a murine model of metabolic syndrome M Puccetti, M Pariano, M Borghi, C Barola, S Moretti, R Galarini, P Mosci, ... International Journal of Pharmaceutics 602, 120610, 2021 | 25 | 2021 |
